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Abstract
In Chagas disease, CD8+ T-cells are critical for the control of Trypanosoma cruzi during acute infection. Conversely, CD8+ T-
cell accumulation in the myocardium during chronic infection may cause tissue injury leading to chronic chagasic
cardiomyopathy (CCC). Here we explored the role of CD8+ T-cells in T. cruzi-elicited heart injury in C57BL/6 mice infected
with the Colombian strain. Cardiomyocyte lesion evaluated by creatine kinase-MB isoenzyme activity levels in the serum and
electrical abnormalities revealed by electrocardiogram were not associated with the intensity of heart parasitism and
myocarditis in the chronic infection. Further, there was no association between heart injury and systemic anti-T. cruzi CD8+
T-cell capacity to produce interferon-gamma (IFNc) and to perform specific cytotoxicity. Heart injury, however, paralleled
accumulation of anti-T. cruzi cells in the cardiac tissue. In T. cruzi infection, most of the CD8+ T-cells segregated into IFNc+
perforin (Pfn)neg or IFNcnegPfn+ cell populations. Colonization of the cardiac tissue by anti-T. cruzi CD8+Pfn+ cells paralleled
the worsening of CCC. The adoptive cell transfer to T. cruzi-infected cd82/2 recipients showed that the CD8+ cells from
infected ifnc2/2pfn+/+ donors migrate towards the cardiac tissue to a greater extent and caused a more severe
cardiomyocyte lesion than CD8+ cells from ifnc+/+pfn2/2 donors. Moreover, the reconstitution of naı¨ve cd82/2 mice with
CD8+ cells from naı¨ve ifnc+/+pfn2/2 donors ameliorated T. cruzi-elicited heart injury paralleled IFNc+ cells accumulation,
whereas reconstitution with CD8+ cells from naı¨ve ifnc2/2pfn+/+ donors led to an aggravation of the cardiomyocyte lesion,
which was associated with the accumulation of Pfn+ cells in the cardiac tissue. Our data support a possible antagonist effect
of CD8+Pfn+ and CD8+IFNc+ cells during CCC. CD8+IFNc+ cells may exert a beneficial role, whereas CD8+Pfn+ may play a
detrimental role in T. cruzi-elicited heart injury.
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Introduction
Trypanosoma cruzi is the intracellular protozoan that causes
American trypanosomiasis, which is also known as Chagas disease.
In Latin America, 8–15 million people are estimated to currently
be infected with this organism [1]. While 50% of T. cruzi-infected
individuals suffer from an indeterminate form of the disease, the
other 50% develop the digestive or the mild-to-severe cardiac form
of Chagas disease between 10 and 30 years post-infection [2].
There is an emerging consensus that the pathology of chronic
chagasic cardiomyopathy (CCC) is associated with parasite
persistence and an imbalanced host immune response that favors
chronic heart inflammation [3]. However, the cellular mechanisms
leading to tissue damage in CCC are unknown.
CD8+ T-cells are crucial for T. cruzi dissemination control
during the acute infection phase [4]. Based on the predominance
of CD8+ T-cells in the cardiac inflammatory infiltrates of CCC
patients [5] and chronically infected mice [6], the participation of
a portion of these heart-invading cells in the immunopathology has
been proposed [7]. CCC is absent or is less severe in patients with
a significantly higher frequency of circulating interferon-gamma
(IFNc)-producing CD8+ T-cells that are specific for T. cruzi [8,9].
In addition, there is a correlation between the number of IFNc-
producing cells and the lack of T. cruzi antigens in the heart lesions
of CCC patients [10]. Adopting experimental murine models, we
confirmed the presence of IFNc mRNA and protein [6,11,12] in
the cardiac tissue at the different stages of T. cruzi infection.
However, there is no clear association between CD8-enriched
myocarditis, which occurs in an IFNc-containing milieu [12], and
heart injury. Conversely, infiltrating CD8+ cells expressing
granzyme A but devoid of the natural killer cell marker CD57
were in contact with myocardial cells in heart biopsies from CCC
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patients [13], suggesting a role for cytolytic CD8+ T-cells (CTL) in
cardiomyocyte lesion. Corroborating these data, the deficiency of
perforin (Pfn), a component of the CTL machinery [14], resulted
in less severe cardiomyocyte lesion and electrical abnormalities
during chronic T. cruzi infection [7].
CD8+ T-cells mediate protection against infection through the
secretion of cytokines, such as IFNc and tumor necrosis factor
(TNF), and through CTL activity via the release of cytotoxic
granules containing granzymes, granulysins and Pfn [14]. In
humans, CD8+ T-cells are functionally segregated into inflamma-
tory (IFNc+Pfnneg) and cytotoxic (IFNcnegPfn+) effectors, which
may influence the outcome of an infectious process [15].
Therefore, we investigated whether CD8+ T-cell effector activities
are segregated into distinct CD8+ populations of inflammatory
(IFNc+) and cytotoxic cells (Pfn+) during a T. cruzi infection.
Furthermore, it is reasonable to propose that the functional
segregation of CD8+ T-cells in vivo has distinct implications for
parasite control and the immunopathology of chronic cardiomy-
opathy. Therefore, adopting a murine model of chronic T. cruzi-
elicited CD8-enriched myocarditis, we analyzed CD8+ T-cells to
clarify whether they are multifunctional (IFNc+Pfn+) or segregated
into inflammatory (IFNc+) and cytotoxic (Pfn+) cells. In addition,
we examined the ability of CD8+ T-cells that selectively express
IFNc or Pfn to colonize the cardiac tissue and investigated
whether they play a role in parasitism control or cardiac tissue
injury during T. cruzi infection.
Results
Evolution of T. cruzi-elicited cardiomyocyte lesion and
electrical abnormalities were not associated with the
intensities of parasitism and CD8-enriched myocarditis
Initially, we investigated whether there was an association
between the evolution of heart injury and parasite load in T. cruzi-
infected C57BL/6 mice. The first peripheral blood circulating
parasites were detected at 14 dpi, marking the onset of the acute
infection phase. The peak of parasitemia was observed between 42
and 45 dpi and trypomastigotes were rarely found in the blood at
90 dpi, characterizing the onset of the chronic phase of infection
(Figure 1A). With respect to cardiac parasitism, the first
amastigote forms were detected at 15 dpi, and were frequently
observed inside of myocytes from 30 dpi. The peak of heart
parasitism coincided with the peak of parasitemia (42 dpi). After
60 dpi, the heart parasitism decreased and the parasite pseudo-
cysts were barely detectable at 90 and 120 dpi (Figure 1A),
although small pseudocysts and a few spots of parasite antigens
were detected by IHS in every heart tissue section of all infected
mice at every time point evaluated (data not shown). Therefore, in
this model of T. cruzi infection, there was a correlation between
parasitemia and heart parasitism during the acute and chronic
phases of infection (r2 = 0.797, p,0.001). Approximately 80% of
the infected mice survived the acute infection and developed the
chronic infection (Figure 1B). To explore the heart injury, we
evaluated creatine kinase cardiac isoenzyme MB (CK-MB) activity
levels in serum, a marker of myocardial cell damage [16,17], and
examined ECG registers looking for electrical abnormalities
[7,18]. At 30 dpi, increased CK-MB activity was observed in T.
cruzi-infected C57BL/6 mice when compared with their nonin-
fected counterparts (Figure 1C). The CK-MB activity reached its
highest levels at 90 dpi and remained high during chronic
infection, which is suggestive of continuous cardiomyocyte injury
(Figure 1C). Although during the acute infection there is a
parallelism between cardiac parasitism and CK-MB activity in the
serum (15–45 dpi, r2 = 0.982, p,0.001), no association between
the intensity of cardiac parasitism and the evolution of
cardiomyocyte lesion was noticed after parasite control or in
chronic T. cruzi infection (60–120 dpi, r2 = 0.0399, p.0.05)
(Figure 1D). Compared with sex- and age-matched noninfected
controls, in infected mice, bradycardia was the first significant
ECG alteration and was firstly detected at 30 dpi. During the
course of the infection, the mice presented significantly higher
bradycardia, PR intervals and prolonged QTc intervals when
compared with noninfected controls (Figure 1E and Table 1).
All (100%) of the infected mice presented ECG abnormalities at
90 dpi (Table 1) and featured a delay in the conduction of electric
impulses together with arrhythmia and first- and second-degree
atrioventricular blocks (AVB1 and AVB2). Again, there was no
relationship between the intensity of tissue parasitism and the
evolution of electrical abnormalities. Interestingly, the CK-MB
activity in the serum and the electrical alterations were paralleled
by heart enlargement during the chronic infection phase
(Figure 1F). Therefore, we evaluated whether heart injury was
associated with the establishment and the intensity of CD8-
enriched myocarditis. A kinetic study of heart colonization by
inflammatory CD4+ and CD8+ cells, the major components of
chagasic myocarditis [5,6], in T. cruzi-infected C57BL/6 mice
revealed that rare mononuclear cells were detected in the cardiac
tissue at 15 dpi. CD8-enriched inflammation occurred at 30 dpi,
after which a significant contraction of inflammation was
observed; however, myocarditis that was mainly composed of
CD8+ T-cells persisted during the chronic phase (Figure 1G).
Once again, there was no correlation between CK-MB activity
levels in the serum and the intensity of inflammation (r2 = 0.038,
p.0.05). Flow cytometry analysis of mononuclear cells harvested
from cardiac tissue of T. cruzi-infected C57BL/6 mice confirmed
the predominance of CD8+ T-cells (Figure S1A). A small part of
the TCR+ cells were CD8negCD4+ T-cells. Also, some
CD8negNK1.1+ cells were detected (Figure S1B). Further,
CD8+ cells were mainly TCR+ cells at 40 dpi (Figure S1C).
CD8+ T-cells-enriched myocarditis persisted at 90 dpi (R1 gate:
47.6–73.6% TCRab+: 17.3–19.4% TCR TCRab+CD4+ vs. 28.2–
51% TCR TCRab+CD8+, two independent experiments) when
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Chagas disease, a neglected tropical disease that is caused
by Trypanosoma cruzi, afflicts between 8 and 15 million
people in Latin America. Anti-parasite immunity allows for
acute phase survival; however, approximately 30% of
patients present chronic chagasic cardiomyopathy (CCC)
with parasite persistence and CD8-enriched myocarditis at
10 to 30 years post-infection. The comprehension of the
pathogenesis of Chagas’ heart disease may open a new
avenue of therapy for CCC. Here, we explored the role of
CD8+ T-cells in heart injury in C57BL/6 mice that were
infected with the Colombian strain of T. cruzi. In infected
mice, most of the CD8+ T-cells were segregated into CD8+
interferon-gamma (IFNc)+perforin (Pfn)neg and CD8+IFNcneg
Pfn+ cell populations. Importantly, the enrichment of the
chronic myocarditis in anti-parasite CD8+Pfn+ cells paral-
leled the worsening of CCC. CD8+ cells from infected ifnc2/2
pfn+/+ donors migrated towards the cardiac tissue to a
greater extent than did CD8+ cells from ifnc+/+pfn2/2
donors. Moreover, accumulation of IFNc+ cells in the cardiac
tissue ameliorated cardiomyocyte lesion, whereas enrich-
ment in CD8+Pfn+ cells aggravated cardiomyocyte injury.
Therefore, our data suggest that CD8+IFNc+ cells are
beneficial, whereas CD8+Pfn+ cells are detrimental in T.
cruzi-elicited heart injury.
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Figure 1. C57BL/6 mice infected with the Colombian strain of T. cruzi develop chronic cardiomyopathy. Mice were infected with 100 bt
of the Colombian strain of T. cruzi and parasitological and clinical parameters were evaluated. (A) Kinetics of parasitemia and cardiac parasitism. (B)
Survival rate. (C) CK-MB activity levels in the serum of noninfected and T. cruzi-infected mice. (D) Positive correlation between cardiac tissue
parasitism and CK-MB activity levels during the acute phase (r2 = 0.982) but not during the chronic phase (r2 = 0.039) of infection. (E) Representative
ECG register segments of 1200 ms of sex- and age-matched noninfected (NI) controls and T. cruzi-infected C57BL/6 mice at 30, 45, 60, 90 and 120 dpi,
showing arrhythmia and first and second degree atrioventricular block (AVB1, AVB2; arrows) in infected mice. (F) Relative heart weight (mg/g) of
CD8+ T-Cells in Experimental Chagas’ Heart Disease
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the highest level of CK-MB activity in the serum, demarking the
cardiomyocyte lesion (Figure 1C), was detected.
Therefore, the present findings show that chronic cardiomyop-
athy in C57BL/6 mice is not associated with the intensity of heart
parasitism or inflammation, even though cardiomyocyte lesion and
electrical abnormalities occurred in the persistence of the parasite
and the CD8-enriched inflammation in this tissue. Collectively,
these data show that this model reproduces several features of the
CCC that has been described in patients [2] and it is an
appropriate model for this study.
Chronic heart injury was not related to the systemic
immune response but paralleled the accumulation of
anti-T. cruzi VNHRFTLV ASP2 effector CD8+ T-cells in the
cardiac tissue
Next, we investigated whether the induction of the anti-T. cruzi
CD8-mediated immune response involving IFNc production and
the cytotoxic machinery was related to heart injury. In spleen of T.
cruzi-infected mice, the ex vivo H-2Kb-restricted anti-VNHRFTLV
ASP2 peptide [19,20] IFNc-secreting cells (Figure 2A) and in vivo
cytotoxic CD8+ T-cells (Figure 2B) were first detected at 15 dpi.
Both of these CD8+ T-cell effector activities rose quickly, reaching a
maximum at the parasitemia peak (45 dpi) and remaining high until
60 dpi. Both of the anti-VNHRFTLV CD8+ T-cell effector activities
declined slowly thereafter, but they persisted after parasite control
and remained detectable at 120 dpi (Figure 2A and 2B). Thus,
during the acute phase (from 15 to 45 dpi) the increase of both CD8+
T-cell effector activities (inflammatory and cytolytic) in the spleen
paralleled the parasitic load in the blood and in cardiac tissues. At
60 dpi, after the parasitemia and heart parasitism were under
control (Figure 2A and 2B), there was contraction of these CD8+
T-cell effector activities, as expected. However, anti-VNHRFTLV
CD8+ T-cell effector activities (inflammatory and cytolytic) persisted
during the chronic infection and were associated with an increased
spleen weight and cellularity (Figure S2A and S2B), although these
effector activities were not proportional to the parasite load
(Figure 2A and 2B). Moreover, during the chronic infection, no
relationship was observed between the intensity of the systemic anti-
VNHRFTLV CD8+ T-cell effector activities and cardiomyocyte
lesion, as evidenced by the observation that the highest CK-MB
activity level in the serum was detected at 90 dpi, which follows the
contraction of CD8+ T-cell effector activities (inflammatory and
cytolytic) (Figure 2A and 2B). Importantly, using the major
histocompatibility complex class I (MHC I) multimer H-2Kb/
VNHRFTLV, a critical reagent for proper visualization of specific
CD8+ T-cells [21], we revealed the presence of anti-VNHRFTLV
ASP2 peptide CD8+ T-cells in spleen and cardiac tissue of the
Colombian-infected C57BL/6 mice (Figure 2C). The analysis of
CD8+ H-2Kb/VNHRFTLV+ T-cells in spleen (Figure 2D)
confirmed the kinetic of the frequency of anti-VNHRFTLV CD8+
T-cells in this tissue detected by ex vivo ELISpot and in vivo cytolytic
assay. Further, the frequency of blood circulating CD8+ H-2Kb/
VNHRFTLV+ T-cells reflected the high frequency of these cells in
the spleen in the acute infection and the contraction of these
populations in the chronic infection (Figure 2D). Conversely, there
was an enrichment in CD8+ H-2Kb/VNHRFTLV+ T-cells among
heart infiltrating inflammatory cells in the acute infection that
persisted during the chronic phase of infection (Figure 2D),
paralleling the persisting myocardial cell injury (Figure 1C).
Heart injury is associated with the enrichment of Pfn+
cells in the cardiac tissue during the chronic T. cruzi
infection
As described above, IHS and flow cytometry analysis showed
that CD8-enriched myocarditis was established early during the T.
cruzi infection. Initially, we adopted an in situ IHS approach to
noninfected (NI, pool of three age-matched controls per analyzed point) and T. cruzi-infected C57BL/6 mice at 15, 30, 45, 60, 90 and 120 dpi. (G)
Numbers of CD4+ and CD8+ cells in the cardiac tissue during acute and chronic T. cruzi infection were counted after immunohistochemistry staining.
Each circle represents an individual mouse. These data represent three independent experiments. *, p,0.05, **, p,0.01, and ***, p,0.001 comparing
NI controls and T. cruzi-infected mice.
doi:10.1371/journal.ppat.1002645.g001
Table 1. Electrocardiograph parameters of C57BL/6 mice infected with the Colombian T. cruzi strain.
Groups
Heart rate1
(bpm)
PR interval
(ms)
P duration
(ms)
QRS duration
(ms) QTc (ms)
Cardiac conduction
(% of mice)2
Frequency of
afflicted mice (%)
Noninfected 637670.7 3561.1 962.1 1161.5 7765.7 ART (0%), AVB1
(0%), AVB2 (0%)
0
T. cruzi 30 dpi 491636.2 4162.8 1361.2 1362.3 8165.1 ART (43%), AVB1
(43%), AVB2 (28%)
70
T. cruzi 60 dpi 496651.3*,3 4664.2* 1463.7 1460.8 8666.2 ART (57%), AVB1
(43%), AVB2 (43%)
86
T. cruzi 90 dpi 450661.6** 4766.3* 1460.9 1361.2 88613.3* ART (67%), AVB1
(43%), AVB2 (57%)
100
T. cruzi 120 dpi 433664.4*** 4564.7* 1463.0 1361.1 89611.6** ART (72%), AVB1
(28%), AVB2 (72%)
100
1ECG parameters were evaluated using the following standard criteria: (i) heart rate (monitored by beats per minute (bpm), and (ii) the variation of the P wave and PR,
QRS and corrected QT intervals (QTc), all measured in milliseconds (ms). ART, arrhythmia; AVB1, first-degree atrioventricular block; AVB2, second-degree atrioventricular
block.
2This data represent three independent experiments, with 7–8 infected mice/group. Three sex- and age-matched noninfected controls were analyzed in all experimental
time points. The results were pooled in one representative group of 12 noninfected controls per experiment.
3Significant differences
*, p,0.05;
**, p,0.01;
***, p,0.001 between the values for noninfected and T. cruzi-infected groups of mice.
doi:10.1371/journal.ppat.1002645.t001
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investigate whether inflammatory (IFNc+) and cytotoxic (Pfn+)
cells differentially colonize the cardiac tissue at different time
points during T. cruzi infection. We evaluated the number of Pfn+
and IFNc+ cells within the myocardium of C57BL/6 mice at 15,
30, 60, 90 and 120 dpi and revealed that IFNc+ cells are detected
at 15 dpi (Figure 3A), preceding the appearance of Pfn+ cells,
which were first detected at 30 dpi (Figure 3B). Furthermore, the
highest number of IFNc+ cells was observed at 45 dpi, which
coincides with the heart parasitism peak (Figure 3C), whereas the
number of Pfn+ cells peaked at 60 dpi (Figure 3D). At 120 dpi,
there was a significant (p,0.05) reduction in the number of IFNc+
cells infiltrating the cardiac tissue, whereas the Pfn+ cell number
remained high (Figure 3A and 3B). Therefore, the ratio of
IFNc+ to Pfn+ cells decreased and resulted in a relative enrichment
of Pfn+ cells among the inflammatory cells that invaded the
cardiac tissue as the infection approached the chronic phase
(Table 2). Next, we determined whether the control of the
parasite and the cardiomyocyte lesion were in any way related to
the presence of IFNc+ and Pfn+ cells in the cardiac tissue in
response to T. cruzi infection. The analysis of the IHS data showed
that the heart parasitism was under control only after 60 dpi when
both Pfn+ and IFNc+ cells were detected in high numbers in the
cardiac tissue (Figure 3C and 3D). Importantly, in the chronic
infection cardiomyocyte lesion was not related to the presence of
IFNc+ cells (r2 = 0.052), but correlated with the persistence of high
number of Pfn+ cells (r2 = 0.662) invading the cardiac tissue
(Figure 3C and 3D). Interestingly, the distribution of Pfn+ cells
in the cardiac tissue was more focal, whereas the IFNc+ cells were
spread throughout the myocardium (Figure 3E). Taken together,
these data suggest a role for the infiltrating inflammatory Pfn+ cells
in heart injury during T. cruzi infection.
Segregation of CD8+ T-cells into IFNc+Pfnneg and
IFNcnegPfn+ populations in T. cruzi infection
The kinetics of cardiac tissue colonization by IFNc+ and Pfn+
cells suggest that the inflammatory and cytotoxic effector activities
were segregated into different cell populations. Therefore, we
investigated whether CD8+ T-cells express IFNc and Pfn in a
multifunctional or segregated manner during T. cruzi infection.
Peripheral blood CD8+ T-cells (Figure 4A), which potentially
migrate to the cardiac tissue, from acute and chronically T. cruzi-
infected C57BL/6 mice were assessed for intracellular IFNc and
Pfn expression. In comparison with noninfected mice, there was a
significant increase in the frequency of CD8+ T-cells expressing
IFNc and Pfn in the peripheral blood of T. cruzi-infected mice
(Figure 4B and 4 C). Indeed, most of the CD8+ T-cells
segregated into CD8+IFNc+Pfnneg (CD8+IFNc+) and CD8+IFNcneg
Pfn+ (CD8+Pfn+) cell populations (Figure 4B). In the circulating
blood, there was a predominance of CD8+IFNc+ cells in
comparison with CD8+Pfn+ cells during the acute (45 dpi) and
chronic (120 dpi) phases of the infection (Figure 4B and 4C).
CD8+IFNc+Pfn+ cells were barely detected in noninfected and T.
cruzi-infected mice, although a careful analysis revealed an
upregulation of this rare CD8+ T-cell population during the chronic
infection (from 0.01–0.05% in noninfected to 0.19–0.34% in
chronically infected mice). Interestingly, during the chronic
infection there was an accumulation of CD8+IFNc+ cells in the
peripheral blood, whereas a decrease in the frequency of CD8+Pfn+
cells was detected (Figure 4B and 4C). Collectively, these data
suggest that in the peripheral blood most of the CD8+ T-cell
effectors potentially able to perform inflammatory and cytotoxic
activities are phenotypically segregated, respectively, into
CD8+IFNc+ and CD8+Pfn+ T-cells during the acute and chronic
phases of T. cruzi infection. Importantly, this segregation of CD8+ T-
cells into CD8+IFNc+ and CD8+Pfn+ populations was also detected
in the inflammatory cells infiltrating the cardiac tissue at 45 and
120 dpi (Figure 4D). In addition, the cardiac tissue infiltrating
CD8+IFNc+ cells were IFNcdull (MFI = 33.4–38.66) when com-
pared with the CD8+IFNc+ cells in peripheral blood
(MFI = 144.12–166.81). Moreover, in the cardiac tissue there was
prevalence of CD8+Pfn+ cells in the acute and, particularly, in the
chronic T. cruzi infection (Figure 4D and 4E).
Considering the recent finding showing a role for interleukin
(IL)-10 in T. cruzi-triggered myocarditis [22], we studied whether
or not CD8+IFNc+ cells coexpress IL-10 during T. cruzi infection.
The analysis of CD8+ T-cells in the peripheral blood revealed that
most of the IFNc+ cells were CD8+IFNc+IL-10+ in the acute and
in the chronic infection (Figure S3A) and accumulated in blood in
the chronic phase of infection (Figure S3B). Further, there was a
significant frequency of CD8+IFNc+IL-10neg T-cells accumulating
in the peripheral blood in the chronic infection (Figure S3C).
More important, in the heart tissue most of the CD8+IFNcdull cells
do not express IL-10 (Figure S3D) or express this cytokine in a
very transient manner and were not detected in our experimental
approach.
Differential compartmentalization of anti- T. cruzi CD8+ T-
cells expressing IFNc and Pfn
The accumulation of CD8+IFNc+ cells in the peripheral blood
and the enrichment in CD8+Pfn+ cells in the cardiac tissue during
the chronic T. cruzi infection led us to investigate whether or not
there was distinct distribution of the CD8+ H-2Kb/VNHRFTLV+
T-cells expressing IFNc and Pfn in different immune compart-
ments of an infected mice. Indeed, in the spleen there was a
predominance of H-2Kb/VNHRFTLV+ IFNc+ cells, followed by
double-positive IFNc+Pfn+ cells and Pfn+ cells at 120 dpi
(Figure 5A). Therefore, we analyzed the presence of CD8+ H-
2Kb/VNHRFTLV+ cells expressing IFNc and Pfn in the spleen,
peripheral blood and cardiac tissue during the acute and chronic
infection of C57BL/6 mice. In the acute infection (45 dpi), there
Figure 2. CD8+ T-cells recognizing the VNHRFTLV ASP2 T. cruzi peptide are enriched in the cardiac tissue. C57BL/6 mice were infected
with 100 bt of the Colombian strain of T. cruzi and the anti-parasite immune response in the spleen and cardiac tissue was assessed. (A)
Representative spots formed after stimulation of spleen cells from noninfected (NI) and T. cruzi-infected mice at 45 and 120 dpi with H-2Kb-resctricted
VNHRFTLV peptide. The number of CD8+IFNc+ as determined by ex vivo ELISpot were analyzed and compared with parasitemia and CK-MB activity
levels in the serum. (B) Representative histogram profiles of in vivo cytotoxicity assay showing the specific lysis of H-2Kb-resctricted VNHRFTLV
peptide-labeled CFSEhigh cells from NI controls and T. cruzi-infected C57BL/6 mice at 45 and 120 dpi. The frequencies of in vivo specific lysis of with H-
2Kb -resctricted VNHRFTLV peptide-labeled target cells in T. cruzi-infected C57BL/6 mice at 15, 30, 45, 60, 90 and 120 dpi were analyzed and
compared with parasitemia and CK-MB activity levels in the serum. The peak of parasitemia and the maximum CK-MB activity are highlighted (dotted
line). Each circle and vertical lines represent the mean 6 standard deviation (SD) of the studied group (5–7 animals/time point). These data represent
three independent experiments. (C) Frequency of double-positive CD8+ H-2Kb /VNHRFTLV+ cells [R1 (SSCxFSC) gated] of spleen and heart of NI and T.
cruzi-infected C57BL/6 mice at 40 dpi. (D) Frequencies of double-positive CD8+ H-2Kb /VNHRFTLV+ cells [R1 (SSCxFSC) gated] of spleen, peripheral
blood and heart of NI and T. cruzi-infected C57BL/6 mice at 30, 45 and 120 dpi. Representative flow ctometry profiles and mean6 SD of two or three
animals per group. Bars represent the mean of two or three pools of 5 mice per pool.
doi:10.1371/journal.ppat.1002645.g002
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was predominance of H-2Kb/VNHRFTLV+ Pfn+ cells in the
spleen, peripheral blood and cardiac tissue inflammatory CD8+ T-
cells (Figure 5B). Moreover, in the chronic phase of infection
(120 dpi) the accumulation of CD8+ H-2Kb/VNHRFTLV+
IFNc+ cells in spleen was confirmed. Anti-T. cruzi IFNc+Pfn+
cells were also retained in the spleen at 120 dpi (Figure 5C). In
contrast, similar frequencies of segregated CD8+ H-2Kb/
VNHRFTLV+ IFNc+ or Pfn+ cells were detected in peripheral
blood, while the enrichment in CD8+ H-2Kb/VNHRFTLV+ Pfn+
cells among heart infiltrating inflammatory cells persisted at
120 dpi (Figure 5C), paralleling the myocardial cell injury
(Figure 1C).
Figure 3. IFNc+ and Pfn+ cells differentially invade the cardiac tissue of T. cruzi-infected C57BL/6 mice. Mice were infected with 100 bt of
the Colombian strain of T. cruzi and the presence of IFNc+ and Pfn+ cells in the cardiac tissue was evaluated by IHS. (A) Numbers of IFNc+ cells
infiltrating the cardiac tissue at 15, 30, 45, 60, 90 and 120 dpi. (B) Numbers of Pfn+ cells infiltrating the cardiac tissue at 15, 30, 45, 60, 90 and 120 dpi.
(C) Relationship between IFNc+ cells infiltrating the cardiac tissue and heart parasitism or CK-MB activity in serum. (D) Relationship between Pfn+ cells
infiltrating the cardiac tissue and heart parasitism or CK-MB activity in the serum. (E) Immunohistochemistry staining of IFNc+ (green arrows) and Pfn+
(red arrows) cells infiltrating the cardiac tissue at 60 dpi. In (A) and (B), each circle represents an individual mouse. In (C) and (D), each circle
represents the mean6 SD of the studied group (5–7 animals/time point). These data represent three independent experiments. *, p,0.05; **, p,0.01;
and ***, p,0.001, comparing noninfected (NI) controls and T. cruzi-infected mice. #, p,0.05, comparing T. cruzi-infected mice at 60 and 120 dpi.
doi:10.1371/journal.ppat.1002645.g003
CD8+ T-Cells in Experimental Chagas’ Heart Disease
PLoS Pathogens | www.plospathogens.org 7 April 2012 | Volume 8 | Issue 4 | e1002645
CD8+IFNc+ and CD8+Pfn+ cells differentially express CCR5
and LFA-1
Our findings showed differential accumulation of CD8+IFNc+
cells in the peripheral blood and CD8+Pfn+ T-cells in the cardiac
tissue during the chronic T. cruzi infection (Figure 4). Based on these
findings and on previous data demonstrating that peripheral blood
CD8+CCR5+LFA-1+ cells drastically increase during T. cruzi
infection [12], we next examined whether CCR5 and LFA-1,
molecules essential for the migration of inflammatory cells towards
the cardiac tissue during T. cruzi infection [11,12,23], were
differentially expressed by the CD8+IFNc+ and CD8+Pfn+ cells.
For that, we analyzed the frequencies of CCR5+LFA-1+ cells among
CD8+IFNc+ (Figure S4) and CD8+Pfn+ peripheral blood cells. A
low proportion of peripheral blood CD8+IFNc+ cells were
CCR5+LFA-1+, whereas a high proportion of CD8+Pfn+ cells were
CCR5+LFA-1+ during the acute (45 dpi) and chronic (120 dpi)
phases of infection (Table 3). Therefore, although present at a lower
frequency than CD8+IFNc+ cells in peripheral blood, a higher
proportion of CD8+Pfn+ cells coexpress CCR5 and LFA-1, and they
are potentially more prone to migrate than CD8+IFNc+ cells.
Distinct migratory behavior of CD8+cells from ifnc+/+
pfn2/2 and ifnc2/2pfn+/+ mice towards cardiac tissue
during T. cruzi infection
To investigate whether CD8+IFNc+ and CD8+Pfn+ cells exhibit a
distinct migratory behavior with a differential potential to colonize
the cardiac tissue, a series of adoptive cell transfer experiments was
performed. In brief, ifnc+/+pfn2/2 and ifnc2/2pfn+/+ mice were
infected and their spleens were removed at 20 dpi (100% of the
animals were alive at this time point). The T. cruzi-infected ifnc+/+
pfn2/2 and ifnc2/2pfn+/+ mice presented increased spleen cellularity,
similar to infected C57BL/6 mice (Figure S5A). These infected
ifnc+/+pfn2/2 and ifnc2/2pfn+/+ mice presented similar frequency of
TCR+ cells, but infected ifnc+/+pfn2/2 mice had higher frequency of
CD8+ T-cells (Figure S5A). The CD8+ T-cells from infected ifnc+/+
pfn2/2 mice expressed IFNc, whereas CD8+ T-cells from infected
ifnc2/2pfn+/+ mice expressed Pfn (Figure S5B). Further, CD8+ T-
cells from infected ifnc+/+pfn2/2 and ifnc2/2pfn+/+ mice were
potentially functional as they expressed activation markers as IL-10,
TNF and CD107a (Figure S5B). Therefore, single-cell suspensions
of CD8-enriched cells (from infected ifnc2/2pfn+/+ or ifnc+/+pfn2/2
donors) were prepared using magnetic beads, labeled with CFSE and
intravenously transferred into cd82/2 mice and C57BL/6 mice that
had been infected with T. cruzi 20 days before. At 3, 7 and 10 days
after the cell transfer (dact) (i.e., 23, 27 and 30 dpi; all of the recipient
mice were alive) the hearts were removed from the cd82/2 and
C57BL/6 recipient mice and the CFSE+CD8+ T-cells were
examined and counted under fluorescence and confocal microscopes
(Figure 6A). Our data indicate that more CFSE+CD8+ cells
accumulated in the cardiac tissue of the cd82/2 mice that had
received CFSE+CD8-enriched cells from ifnc2/2pfn+/+ donors
compared with cd82/2 mice that had received CFSE+CD8-enriched
cells from ifnc+/+pfn2/2 donors at all of the assessed time points
(Figure 6B). Although the immunocompetent C57BL/6 recipient
mice that had received CD8+ cells from ifnc+/+pfn2/2 or ifnc2/2pfn+/+
donors accumulated more CFSE+CD8+cells among the inflammatory
cells infiltrating the cardiac tissue compared with the cd82/2
recipients, the preferential accumulation of CFSE+CD8+ cells from
ifnc2/2pfn+/+ donors was reproduced (Figure 6B). The prevalence of
CFSE+CD8+ cells from ifnc+/+pfn2/2 donors in the cardiac tissue of
recipient mice supports distinct migratory behavior of these cells
rather than differential cell proliferation. Indeed, the similar intensities
of fluorescence detected in the CFSE+CD8+ cells from ifnc+/+pfn2/2
and ifnc2/2pfn+/+ donors infiltrating the cardiac tissues of recipients at
3 dact supports that, at least in the initial days after cell transfer, there
was no differential activation of the transferred CFSE+CD8+ cells
(Figure 6C). Moreover, splenocytes from T. cruzi-infected mice,
independently of the mouse lineage, were unresponsive to in vitro
activation with anti-CD3/anti-CD28 stimuli (Figure S5C), while
splenocytes isolated from naı¨ve ifnc+/+pfn2/2mice were more
responsive to anti-CD3/anti-CD28 stimuli (Figure S5C), particularly
the CD8+ T-cells (Figure S5D). Interestingly, similar to what was
detected in T. cruzi-infected C57BL/6 mice, the CFSE+CD8+ cells
from ifnc+/+pfn2/2 donors were diffusely spread in the myocardium
tissue, while the CFSE+CD8+ cells from ifnc2/2pfn+/+ donors were
focally localized among inflammatory cells of the recipient
(Figure 6C). Thus, CD8+IFNcneg (potentially Pfn+) cells migrated
and accumulated in the cardiac tissue more readily than the
CD8+Pfnneg (potentially IFNc+) cells during T. cruzi infection.
Next, we determined whether the differential colonization of the
cardiac tissue of T. cruzi-infected C57BL/6 and cd82/2 recipient
mice by CD8+ T-cells from ifnc2/2pfn+/+ and ifnc+/+pfn2/2
donors had a differential impact on parasite dissemination control
and cardiomyocyte lesion. At 10 dact, similar cardiac tissue
parasitism was observed in recipient mice that had received
CFSE+CD8+ cells from ifnc+/+pfn2/2 or ifnc2/2pfn+/+ donors
(Figure 6D). In C57BL/6 and cd82/2 recipient mice, the
CFSE+CD8+ cells from ifnc+/+pfn2/2 donors had a beneficial
impact on cardiomyocyte lesion as evidenced by a decrease in CK-
MB activity levels in the serum compared with non-transferred
(NT) mice. In contrast, the CFSE+CD8+ cells from ifnc2/2pfn+/+
donors had a detrimental impact as evidenced by the increase in
CK-MB activity levels in the serum compared with their respective
Table 2. Number of IFNc+ and Pfn+ cells in heart tissue sections of T. cruzi-infected C57BL/6 mice.
dpi1 IFNc+ cells /100 fields2 Pfn+ cells /100 fields Ratio of IFNc+/Pfn+ cells3
15 50628 0 50:0
30 54617 561 11:1
45 103645 761 14:1
60 105616 1863 5:1
90 92615 1863 5:1
120 6667 1763 4:1
1dpi, days post-infection with 100 bt of the Colombian T. cruzi strain.
2The number of positive cells for each parameter was counted in 100 microscopic fields per section. Three sections were counted per each analyzed animal.
3Ratio of IFNc+/Pfn+ cells was determined adopting the mean number of positive cells for each parameter per 100 microscopic fields.
doi:10.1371/journal.ppat.1002645.t002
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NT counterparts (Figure 6E). Therefore, these data circumstan-
tially support that CD8+IFNcneg (potentially Pfn+) cells play a non-
beneficial role in heart injury during T. cruzi infection.
Colonization of the cardiac tissue with CD8+Pfn+ T-cells
was correlated with cardiomyocyte lesion
Based on the data presented above, we speculate that
CD8+IFNc+ and CD8+Pfn+ T-cells play distinct roles in the T.
cruzi-elicited cardiomyopathy. To assess this theory, we selectively
reconstituted the CD8 compartment of cd82/2 mice. Briefly, the
spleens were removed from noninfected naı¨ve ifnc2/2pfn+/+ (with
the potential to generate Pfn+ cells) and ifnc+/+pfn2/2 (with the
potential to generate IFNc+ cells) mice and single-cell suspensions
of CD8-enriched T-cells were transferred to noninfected naı¨ve
recipient cd82/2 mice (Figure 7A). The analysis of the peripheral
blood of naı¨ve recipients showed the presence of circulating CD8+
cells (2 to 6.5% of peripheral blood cells) in cd82/2 mice
reconstituted with CD8+ cells from naı¨ve ifnc2/2pfn+/+ and ifnc+/+
Figure 4. Segregation of CD8+ T-cells into IFNc+ and Pfn+ populations in T. cruzi infection. C57BL/6 mice were infected with 100 blood
trypomastigotes of the Colombian strain of T. cruzi and the expression of IFNc+ and Pfn+ by CD8+ cells in the peripheral blood and cardiac tissue was
evaluated. (A) Representative histograms of flow cytometry analysis of peripheral blood CD8+ T-cells [R1 (SSCxFSC)/R2 (TCR)/R3 (CD8) gated] that
were analyzed for IFNc and Pfn expression in T. cruzi-infected mice (120 dpi). (B) Representative dot plots of flow cytometry analysis of peripheral
blood CD8+ T-cells (R1/R2/R3 gated) expressing IFNc and Pfn at 45 and 120 dpi. (C) Frequency of double-stained CD8+IFNc+ and CD8+Pfn+ peripheral
blood T-cells cells (R1/R2/R3 gated) at 45 and 120 dpi. (D) Representative histograms and dot plots of flow cytometry analysis of heart infiltrating
CD8+ cells [R1 (SSCxFSC)/R2 (CD8) gated] expressing IFNc and Pfn at 45 and 120 dpi. (E) Frequency of double-stained CD8+IFNc+ and CD8+Pfn+ of
heart infiltrating cells (R1/R2 gated) at 45 and 120 dpi. In (C) Bars represent the mean 6 SD of five to eight mice per group. In (E) Bars represent the
mean of two or three pools of 5 mice per group. These data represent two or three independent experiments. *, p,0.05; **, p,0.01; and ***, p,0.001,
comparing noninfected (NI) controls and T. cruzi-infected mice. # P,0.05, comparing T. cruzi-infected mice at 45 and 120 dpi.
doi:10.1371/journal.ppat.1002645.g004
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pfn2/2 donors in all analyzed recipient mice at 15 days after cell
transfer (Figure S6), at which time non-reconstituted (NR) and
CD8-reconstituted mice were infected with T. cruzi (Figure 7A).
Parasitemia was monitored every two days and heart parasitism
and injury were evaluated at 30 dpi (at which time all recipient
mice from every experimental group were alive). As expected,
when compared with NR T. cruzi-infected cd82/2 mice at 28 dpi,
the reconstitution of the CD8 compartment with CD8+ cells from
ifnc2/2pfn+/+ or ifnc+/+pfn2/2 donors prior to infection did not
worsen parasitemia. Furthermore, cd82/2 mice that had been
reconstituted with CD8+ T-cells from ifnc2/2pfn+/+ donors
presented reduced parasitemia when compared with NR cd82/2
mice (Figure 7B). All of the animals in every experimental group
survived until 34 dpi. At 35 dpi, the first deaths were recorded in
all groups (Figure 7C). In independent experiments, cardiac
tissue parasitism was analyzed at 30 dpi when 100% of the mice in
all the experimental groups were alive, revealing that the non-
reconstituted cd82/2 mice presented high parasitism, as expected
(Figure 7D). The reconstitution of the cd82/2 mice with CD8+
cells from ifnc+/+pfn2/2 donors neither ameliorated nor aggravat-
ed heart parasitism, whereas the reconstitution of the cd82/2 mice
with CD8+ cells from ifnc2/2pfn+/+ donors significantly reduced
heart parasitism (Figure 7D). To evaluate the participation of the
distinct CD8+ cells populations in heart injury, CK-MB activity
levels in the serum and the ECG registers were evaluated.
Compared with the NR cd82/2 animals, cd82/2 mice that were
reconstituted with CD8+ cells from ifnc+/+pfn2/2 donors exhibited
a significant decrease in CK-MB activity levels in the serum at 10
dact (Figure 7E). In accordance with these findings, the ECG
registers revealed that the reconstitution of cd82/2 recipients of
CD8+ T-cells from ifnc+/+pfn2/2 donors was beneficial, reducing
the frequency of afflicted mice and the severity of the electrical
abnormalities (Table 4). On the other hand, the cd82/2 mice that
had been reconstituted with CD8+ cells from ifnc2/2pfn+/+ donors
exhibited an aggravation of myocardial cell lesion when compared
with NR cd82/2 mice at 10 dact (Figure 7E). Further, the
electrical abnormalities observed in cd82/2 mice that had been
reconstituted with CD8+ T-cells from ifnc2/2pfn+/+ donors prior
to infection were similar to those detected in NR cd82/2 mice
(Table 4).
Interestingly, IHS analysis showed that the reconstitution of
cd82/2 mice with CD8+ cells from ifnc+/+pfn2/2 donors led to a
significant accumulation of IFNc+ cells in the cardiac tissue
(Figure 7F); however, a low number of IFNc+ cells was also
detected in the cardiac tissue of cd82/2 mice that were non-
reconstituted or reconstituted with CD8+ T-cells from ifnc2/2pfn+/+
donors, supporting the existence of non-CD8 IFNc producers in the
cd82/2 mice (probably NK or CD4+ cells). Importantly, in the
cd82/2 mice that were reconstituted with CD8+ T-cells from
ifnc2/2pfn+/+ donors, Pfn+ cells accumulated in the cardiac tissue
(Figure 7G). No Pfn+ cells were detected in the cardiac tissue of
non-reconstituted or cd82/2 mice that were reconstituted with
CD8+ cells from ifnc+/+pfn2/2 donors (Figure 7G), supporting that
all Pfn+ cells detected in the cardiac tissue were CD8+ T-cells.
Because reductions in cardiomyocyte lesion and electrical
Figure 5. Differential compartmentalization of anti-T. cruzi
CD8+ T-cells expressing IFNc and Pfn. C57BL/6 mice were infected
with 100 bt of the Colombian strain of T. cruzi and presence of CD8+ H-
2Kb /VNHRFTLV+ T-cells expressing IFNc+ and Pfn+ in the spleen,
peripheral blood and in the cardiac tissue was evaluated. (A)
Representative dot plots of double-positive CD8+ H-2Kb /VNHRFTLV+
T-cells (R1 gated) in the spleen of NI and T. cruzi-infected C57BL/6 mice
at 120 dpi. Frequencies of CD8+ H-2Kb /VNHRFTLV+ T-cells (R2 gated)
expressing IFNc, Pfn or coexpressing IFNc and Pfn in the spleen,
peripheral blood and cardiac tissue of NI and T. cruzi-infected C57BL/6
mice at 45 (B) and 120 dpi (C). Bars represent the means of two or three
pools of 5 mice per group. These data represent two independent
experiments.
doi:10.1371/journal.ppat.1002645.g005
Table 3. Frequency of CD8+IFNc+ and CD8+Pfn+ coexpressing
CCR5 and LFA-1 among peripheral blood cells during acute
and chronic T. cruzi infection.
Groups
CD8+IFNc+ CCR5+LFA-1+
(%)
CD8+Pfn+ CCR5+LFA-1+
(%)
Noninfected 1.0060.27 1.0160.64
42 dpi (acute) 34.5268.98 53.1265.64
120 dpi (chronic) 1.0160.64 6.3060.38
doi:10.1371/journal.ppat.1002645.t003
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Figure 6. CD8+ cells from ifnc2/2pfn+/+ and ifnc+/+pfn2/2 infected mice differentially migrate to the cardiac tissue. (A) Experimental
scheme showing the infection of donors and recipients mice by T. cruzi, isolation of CD8+ cells from ifnc2/2pfn+/+ and ifnc+/+pfn2/2 infected donors
(20 dpi) by magnetic beads, CFSEhigh labeling, adoptive transfer of CFSE+CD8+ cells to C57BL/6 and cd82/2 infected recipients (20 dpi) and analysis at
3, 7 and 10 days after cell transfer (dact). The colonization of the cardiac tissue by CFSE+ cells, heart parasitism and CK-MB activity levels in the serum
were evaluated. (B) Detection of CFSE+CD8+ cells in cardiac tissue sections at 3, 7 and 10 dact to T. cruzi-infected C57BL/6 and cd82/2 recipients. (C)
Graphics showing the confocal analysis of the intensity of fluorescence of CFSE+CD8+ cells present in the myocardium of cardiac tissue sections at 3
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alterations were observed, the data support the finding that CD8+
IFNc producers colonizing the cardiac tissue play a beneficial role
by decreasing heart injury during T. cruzi infection. Conversely, the
aggravation of cardiomyocyte lesion revealed by increased CK-MB
activity levels in the serum detected in cd82/2 mice that had been
reconstituted with CD8+ T-cells from ifnc2/2pfn+/+ donors
(Figure 7E) was associated with an accumulation of Pfn+ cells in
the cardiac tissue (Figure 7G), reinforcing that CD8+Pfn+ cells play
a detrimental role in heart injury during T. cruzi infection.
Discussion
In Chagas disease, CD8+ T-cells are crucial for T. cruzi
dissemination control during the acute infection phase. In the
chronic infection the predominance of CD8+ T-cells among the
cells infiltrating the cardiac tissue raised the suspicion that these
cells are involved in heart injury. In this study, we adopted a
murine model of T. cruzi-elicited chronic cardiomyopathy to
examine the participation of CD8+ T-cells that express IFNc and
Pfn in parasite control and heart injury. There was no association
of the intensity of heart parasitism and CD8-enriched myocarditis
with cardiomyocyte lesion and electrical abnormalities during the
chronic infection. Furthermore, the expansion and contraction of
anti-VNHRFTLV CD8+ T-cell effector activities (IFNc-producers
and CTL) in the periphery (spleen and blood) were associated with
the parasite load but not with heart injury. The presence, however,
of anti-VNHRFTLV CD8+ effector T-cells in the cardiac tissue
paralleled the tissue damage and electrical abnormalities. The
accumulation of IFNc+ cells preceded the entry of Pfn+ cells into
the cardiac tissue during acute infection. Interestingly, in the
chronic infection, a decrease in IFNc+ and a relative enrichment
in Pfn+ cells invading the cardiac tissue paralleled the worsening of
heart injury. In fact, there was prevalent accumulation of
CD8+Pfn+ cells in the cardiac tissue in T. cruzi infection.
Moreover, there is a differential accumulation of CD8+ H-2Kb/
VNHRFTLV+ Pfn+ T-cells in the cardiac tissue during the chronic
infection. Altogether, these findings led to the idea that CD8+Pfn+
and CD8+IFNc+ exhibit a distinct migratory behavior. Corrob-
orating this theory, CD8+ cells from T. cruzi-infected ifnc2/2pfn+/+
donors (Pfn+) migrate towards the cardiac tissue more so than do
CD8+ cells from ifnc+/+pfn2/2 donors (IFNc+). Moreover, we
demonstrate that the colonization of cardiac tissue of cd82/2 mice
by CD8+Pfn+ cells aggravated cardiomyocyte injury, whereas
CD8+IFNc+ cells ameliorated cardiomyocyte injury and electrical
abnormalities, thus supporting a differential role for CD8+Pfn+
and CD8+IFNc+ T-cells in T. cruzi-elicited cardiomyopathy.
Following infection of C57BL/6 mice with the Colombian strain
of T. cruzi, parasite load was controlled and most of the animals
survived the acute phase of infection and developed a chronic
infection. In these animals, myocardial cell damage and electrical
abnormalities, such as arrhythmias and prolonged QTc interval, are
similar to those described in CCC patients [2,24] and other murine
models of T. cruzi infection [12,20]. Moreover, in T. cruzi-infected
C57BL/6 mice, chronic CD8-enriched myocarditis was associated
with cardiomegaly. Taken together, these data validate this model
for study of the immunopathology of Chagas’ heart disease.
Our first goal was to determine whether the development of
chronic cardiomyopathy, characterized by the presence of
cardiomyocyte lesion and electrical abnormalities, was associated
with the intensity of the parasite load in cardiac tissue and/or
CD8-enriched myocarditis. During the acute infection phase of
C57BL/6 with the Colombian strain of T. cruzi, cardiomyocyte
lesion and electrical alterations were related to heart parasitism
and inflammation. This finding partially corroborated previous
data using a model of acute infection. Briefly, they infected Swiss
mice with the Y strain of T. cruzi and observed a positive
correlation between the intensity of heart inflammation, but not
heart parasitism, and CK-MB activity levels in plasma [16].
Therefore, in C57BL/6 mice acutely infected with the Colombian
strain of T. cruzi, heart injury may be the consequence of the direct
destruction of cardiomyocytes by intense parasitism and/or anti-T.
cruzi effector immunity. However, as infection progresses, heart
parasitism and CD8-enriched myocarditis decreases, coinciding
with the establishment of anti-T. cruzi specific CD8+ T-cell effector
activities (inflammatory and cytotoxic) and parasitemia control,
whereas myocardial cell damage and electrical abnormalities are
aggravated. These data confirm the lack of an association between
the intensity of heart parasitism and myocarditis with the evolution
of heart injury in the chronic phase of T. cruzi infection, as
previously seen in cardiopatic chagasic patients [2,5,25] and
C3H/He mice infected with the Colombian strain of T. cruzi [12].
Therefore, our data reinforce the concept that long-term heart
inflammation, rather than its intensity, is crucial for the generation
of T. cruzi-elicited heart injury.
In spite of their importance for host resistance in T. cruzi
infection [4], CD8+ T-cells gained particular attention as the
major component of myocarditis in acute [26] and chronic [6]
experimental infection, and in chronic chagasic patients [5,13].
Therefore, we compared the kinetics of the generation of
inflammatory (IFNc producers) and cytotoxic CD8+ T-cell
effectors specific for the immunodominant VNHRFTLV ASP2
epitope, which is linked to protective immunity against T. cruzi
[27,28] and is a prototype for general CD8+ T-cell activation, with
the kinetics of the appearance of cardiomyocyte lesions and
electrical abnormalities. The H-2Kb-restricted anti-VNHRFTLV
cytotoxic and IFNc-secreting CD8+ T-cells were first detected
before the peak of parasitemia at 15 dpi and reached a maximum
level at the peak of parasitemia and heart parasitism (42–45 dpi).
This finding contrasts with previous data showing that the peak of
anti-VNHRFTLV cytotoxic and IFNc-secreting CD8+ T-cells
occurred after the peak of parasitemia (between 14 and 24 dpi in
the studied strains), implying that there is a requirement for rounds
of parasite multiplication to trigger CD8+ T-cell effector activities
[29]. In light of these data, it appears that during T. cruzi infection,
specific CD8+ T-cell effectors (IFNc producers and cytolytic
effectors) require between 15 and 20 dpi to proliferate and
differentiate independent of the mouse lineage, parasite strain
(virulence and inoculum size) and parasite load requirements. As
expected, after parasite control (60 dpi) CD8+ T-cell effectors
(IFNc producers and cytolytic effectors) decreased but persisted at
detectable levels up to 120 dpi. Importantly, in the periphery the
maximum anti-VNHRFTLV ASP2 epitope CD8+ T-cell effector
dact to T. cruzi-infected cd82/2 recipients. DAPI was used to reveal the nucleus of the cells of the recipient mice. (D) Number of amastigote nests in
100 microscopic fields of cardiac tissue from C57BL/6 and cd82/2 infected mice that were non-transferred (NT) or transferred with CD8+ cells from
ifnc2/2pfn+/+ and ifnc+/+pfn2/2 donors, at 10 dact. (E) Cardiomyocyte lesions were evaluated at 10 dact by measuring the CK-MB activity in serum
samples from C57BL/6 and cd82/2 infected mice that were non-transferred (NT) or transferred with CD8+ cells from ifnd2/2pfn+/+ and ifnc+/+pfn2/2
donors. Each symbol represents an individual mouse. These data represent three independent experiments. *, p,0.05; **, p,0.01; and ***, p,0.001,
comparing C57BL/6 and cd82/2 infected mice that were non-transferred and transferred with CD8+ cells from ifnc2/2pfn+/+ and ifnc+/+pfn2/2 donors.
doi:10.1371/journal.ppat.1002645.g006
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Figure 7. Distinct migratory behavior and effector function of CD8+IFNc+ and CD8+Pfn+ T-cells in T. cruzi infection. (A) Experimental
scheme of CD8+ cell isolation from noninfected naı¨ve ifnc2/2pfn+/+ and ifnc+/+pfn2/2 donors, in vivo reconstitution of the CD8+ cell compartment of
naı¨ve cd82/2 mice, infection with 100 bt of the Colombian strain at 15 days after cell transfer (dact) and analysis at 30 days post-infection. Parasitemia,
survival rate, cardiac parasitism and CK-MB activity levels in the serum and colonization of the cardiac tissue by IFNc+ and Pfn+ cells were evaluated.
(B) Parasitemia and (C) survival curve of cd82/2 mice non-reconstituted (NR) or reconstituted with CD8+ cells from ifnc+/+pfn2/2 and ifnc2/2pfn+/+
donors. In independent experiments, the animals were analyzed at 30 dpi when 100% of the mice in all the experimental groups were alive (arrow).
(D) Number of amastigote nests in 100 microscopic fields of cardiac tissue sections. (E) Cardiomyocyte lesion evaluated by CK-MB activity in serum
samples. The number of (F) IFNc+ and (G) Pfn+ cells in 100 microscopic fields of cardiac tissue sections from mice non-reconstituted (NR) or
reconstituted with CD8+ cells from ifnc+/+pfn2/2 and ifnc2/2pfn+/+ donors, at 30 dpi. Each symbol represents an individual mouse. These data
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cytotoxic and inflammatory activities was achieved at the
parasitemia peak (42–45 dpi) and was probably stimulated by
the proportional release of parasite antigens. Importantly, it was
not kinetically related to the more severe heart injury that was
observed at a later time (90 dpi). Therefore, protective CD8+ T-
cell effectors controlling T. cruzi growth in the periphery and
detrimental myocarditis appear to be dissociated facets of the host
immune response that is triggered by the invading organism
[12,23]. If so, one may be able to stimulate anti-parasite protective
immunity and selectively downregulate the detrimental inflamma-
tion colonizing the cardiac tissue. Therefore, an understanding of
the functional role played by the cells invading the cardiac tissue is
required. Our next goal was to establish the kinetics of the heart
colonization by inflammatory cells during T. cruzi infection to
determine the association with heart injury. CD8-enriched
myocarditis was established during acute infection and although
inflammation decreased as a whole, CD8+ T-cells persisted as the
predominant cell population invading the cardiac tissue during the
chronic phase of infection, corroborating findings observed in
patients [5,13] and C3H/He mice infected with the Colombian T.
cruzi strain [6]. Previous data demonstrated that IFNc is crucial for
regulation of the entry of anti-parasite protective cells into the
cardiac tissue [11], and a Pfn deficiency results in less severe
cardiomyocyte lesion and electrical abnormalities during chronic
T. cruzi infection [7]. Therefore, we investigated whether IFNc+
and Pfn+ cells colonize the cardiac tissue simultaneously or in a
dissociated manner during T. cruzi infection, and examined the
possible implications of this scenario in chronic cardiomyopathy.
The entry of IFNc+ cells into the cardiac tissue preceded the influx
of Pfn+ cells, suggesting that inflammatory and cytotoxic effector
activities are performed by distinct cell populations during a T.
cruzi infection. Indeed, most of the CD8+ T-cells that were
detected in the peripheral blood of acute and chronically T. cruzi-
infected mice were segregated into CD8+IFNc+ and CD8+Pfn+
cell populations. Importantly, these ex vivo stained cells reflect the
status of in vivo activated cells that are present in peripheral blood
and migrate to tissues that are targeted by T. cruzi, e.g., the cardiac
tissue. Furthermore, this segregation is a long-term feature as
opposed to a transient characteristic of distinct inflammatory
(IFNc producers) and cytotoxic (Pfn-expressing) CD8+ T-cell
effectors in acute and chronic T. cruzi infection. In fact, in the
cardiac tissue the accumulation of segregated CD8+Pfn+ T-cells
observed in the acute infection persisted in the chronic phase of
infection. Moreover, the CD8+IFNc+ T-cells detected in the
cardiac tissue are IFNcdull. Thus, this pale expression of IFNc by
the inflammatory cells invading the cardiac tissue, that confirmed
previous data [30], may be related to continuous in situ antigenic
stimulation.
The possibility of coexpression of IFNc and Pfn by a single
CD8+ T-cell under antigen re-stimulation conditions cannot be
ruled out. Indeed, there was a low but consistent increased
frequency of CD8+ T-cells in the peripheral blood T. cruzi-infected
mice (from 0.01–0.05% in noninfected to 0.19–0.34% in
chronically infected mice). Further, anti-T. cruzi CD8+IFNc+Pfn+
T-cells were retained in the spleen during chronic infection. In this
context, a recent report showed that following the in vitro
restimulation with human immunodeficiency virus antigens,
peripheral blood CD8+ T-cells from elite controllers presented a
higher frequency of IFNc+Pfn+ responders than CD8+ T-cells
from chronic progressors [31]. Therefore, it remains to be
determined whether the segregation of effector activities in
CD8+IFNc+ and CD8+Pfn+ T-cells is a T. cruzi-driven feature
that contributes to parasite escape and persistence in chronic
infection. Furthermore, if this is the case, it is reasonable to
suppose that the stimulation of anti-T. cruzi immunity during
chronic infection, for example, through immunotherapeutic
vaccination, would upregulate multifunctional CD8+IFNc+Pfn+
T-cells.
A predominance of CD8+IFNc+ cells compared with CD8+Pfn+
T-cells was consistently detected in the peripheral blood of
represent three independent experiments. *, p,0.05; **, p,0.01; and ***, p,0.001, comparing cd82/2 infected mice non-reconstituted and
reconstituted with CD8+ cells from ifnc2/2pfn+/+ and ifnc+/+pfn2/2 donors.
doi:10.1371/journal.ppat.1002645.g007
Table 4. Electrocardiograph parameters of cd82/2 mice adoptively transferred with CD8+ cell from ifnc2/2pfn+/+ or ifnc+/+pfn2/2
and infected with the Colombian T. cruzi strain.
Groups1
Heart rate2
(bpm)
PR interval
(ms)
P duration
(ms)
QRS duration
(ms) QTc (ms)
Cardiac conduction
(% of mice)3
Frequency of
afflicted mice (%)
cd82/2 NI 522667 3565.9 1261.9 1162.1 70611.3 ART (0%), AVB1
(0%), AVB2 (0%)
0
cd82/2 (NR) T. cruzi 311659*,4 3864.1 1662.4* 1461.3* 10666.8* ART (60%), AVB1
(0%), AVB2 (100%)
100
cd82/2AdT-CD8+pfn2/2 T. cruzi 465680# 3464.9 1262.3# 1362.6 88611.0 ART (40%), AVB1
(20%), AVB2 (60%)
80
cd82/2AdT-CD8+ifnc2/2 T. cruzi 341697 4262.6 1563.2 1667.1 109615.8 ART (80%), AVB1
(0%), AVB2 (100%)
100
1cd82/2 mice were: NI, non-infected; T. cruzi, infected with 100 bt forms of the Colombian T. cruzi strain 15 days after adoptive cell transfer (AdT) of CD8-enriched cells
($98%), obtained from IFNc-deficient (ifnc2/2pfn+/+) or Pfn-deficient (ifnc+/+pfn2/2) mice.
2ECG parameters were evaluated using the following standard criteria: (i) heart rate (monitored by beats per minute (bpm), and (ii) the variation of the P wave and PR,
QRS and corrected QT intervals (QTc), all measured in milliseconds (ms). ART, arrhythmia; AVB1, first-degree atrioventricular block; AVB2, second-degree atrioventricular
block.
3This table represented accumulated data from three independent experiments, with 3 to 5 mice/group in each experiment.
4Significant differences:
*, p,0.05 - between the values for cd82/2 noninfected and T. cruzi-infected mice;
#, p,0.05 - between the values for cd82/2 non-reconstituted and cd82/2 reconstituted and infected with T. cruzi.
doi:10.1371/journal.ppat.1002645.t004
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C57BL/6 mice during the acute and chronic phases of T. cruzi
infection. Independent of the lower frequency of CD8+Pfn+ cells
available in the blood, we noticed a gradual relative accumulation
of Pfn+ cells in the cardiac tissue as the T. cruzi infection evolved
into the chronic phase. Therefore, we were interested in
determining whether these CD8+ T-cells expressing IFNc+ and
Pfn+ in a segregated form represent a distinct status of molecules
involved in the process of cell migration. Indeed, CD8+Pfn+ T-
lymphocytes have a higher frequency of CCR5+LFA-1+ cells
compared with CD8+IFNc+ T-cells. Interestingly, there was a
decrease in the proportion of CD8+Pfn+ cells and an increase in
the frequency of CD8+IFNc+ cells in the peripheral blood during
the chronic infection. Importantly, there was accumulation of
CD8+Pfn+ cells in relation to CD8+IFNc+ cells in the cardiac tissue
independently of the prevalence of CD8+IFNc+ cells in the
peripheral blood of chronically infected mice. A high frequency of
CD8+IFNc+ cells in the peripheral blood of patients with severe
CCC was interpreted as participation of this population of cells in
immunopathogenesis [32]. However, we believe that this concept
should be re-interpreted because the evidence suggests that the
findings in the peripheral blood do not reflect the scenario of the
cellular environment of the cardiac tissue.
The intensity of acute and chronic T. cruzi-elicited myocarditis
is related to the concentrations of the CC-chemokines CCL3/
MIP-1a and CCL5/RANTES, but not to the concentrations of
IFNc and TNF in the cardiac tissue [12]. Furthermore, 100% of
the CD8+ cells that colonize the heart tissue express the CC-
chemokine receptor CCR5 [23,33] and the cell adhesion
molecule LFA-1 [6], suggesting that CCR5+LFA-1+ cells
colonized the cardiac tissue during T. cruzi infection and retain
this activation phenotype. Most of the cardiomyocytes express the
LFA-1 ligand ICAM-1 [34,35]. Moreover, besides being key
molecules in cell migration, LFA-1 and CCR5 play roles in
immunological synapses and cell activation [36,37]. Therefore,
both CCR5 and LFA-1 expressed by CD8+ effector T-cells (either
IFNc+ or Pfn+) may play roles in parasite control or cytotoxic
activity in the cardiac tissue. ICAM-1-deficient mice exhibit poor
migration of CD4+ and CD8+ T-cells towards the cardiac tissue,
where the parasite is less controlled [11]. In addition, T. cruzi-
infected CCR5-deficient mice experience dramatically inhibited
migration of T-cells to the cardiac tissue and are more susceptible
to infection, demonstrating that CCR5 and its ligands play a
central role in the control of T-cell influx towards the cardiac
tissue in T. cruzi-infected mice [33,38]. However, the partial
blockage of the CC-chemokine receptors CCR1/CCR5 using
Met-RANTES during T. cruzi infection was beneficial as it did
not interfere with the control of heart parasitism but significantly
reduced the numbers of CD4+, CD8+ and CCR5+ lymphocytes
in the cardiac tissue during acute infection [23]. During chronic
infection, Met-RANTES inhibited connexin 43 loss and de-
creased cardiomyocyte lesion [12]. These data suggest that not all
CCR5+ cells are crucial for parasite control, and at least some of
the cells play a pivotal role in the pathogenesis of T. cruzi-elicited
cardiomyopathy. In this context, our data indicate that because a
larger proportion of CD8+Pfn+ cells than CD8+IFNc+ cells were
CCR5+LFA-1+, these CD8+Pfn+ cells may exhibit a differential
migratory behavior that favors their accumulation in the cardiac
tissue, contributing to explain the observed accumulation of
CD8+Pfn+ cells in the cardiac tissue in chronically T. cruzi-
infected C57BL/6 mice. The adoptive cell transfer of CD8+ T-
cells from ifnc2/2pfn+/+ and ifnc+/+pfn2/2 infected donors to
C57BL/6 and cd82/2 infected recipient mice circumstantially
support this idea because CD8+ T-cells from ifnc2/2pfn+/+
infected donors (expressing Pfn) accumulated in the cardiac
tissue to a greater extent than CD8+ T-cells that had been
isolated from ifnc+/+pfn2/2 infected donors (expressing IFNc).
Therefore, this differential migratory behavior of CD8+ cells that
express Pfn, but do not produce IFNc, might explain the gradual
relative accumulation of Pfn+ cells in the cardiac tissue during T.
cruzi infection. This was confirmed by the flow cytometry study
showing the accumulation of CD8+Pfn+ T-cells in relation to
CD8+IFNc+ cells in the cardiac tissue. Furthermore, in the cell
transfer experiments, we noticed that independent of the heart
parasitism that remained equal in all experimental groups, the
differential entry of CD8+ T-cells into the cardiac tissue was
sufficient to produce distinct cardiomyocyte lesion profiles at 10
days after cell transfer. Interestingly, in both C57BL/6 and cd82/2
infected recipient mice, CD8+ T-cells from ifnc2/2pfn+/+ infected
donors (produce Pfn) were implicated in myocardial cell damage,
whereas CD8+ T-cells from ifnc+/+pfn2/2 infected donors (produce
IFNc) contributed to the amelioration of cardiomyocyte lesion.
Interestingly, as heart parasitism was similar in these groups, the
beneficial role of the CD8+ T-cells originating from ifnc+/+pfn2/2
infected donors was not due to the parasite control in this case.
Therefore, these cells might favor cardiomyocyte integrity
through other mechanisms that remain to be explored. A recent
study supports that at 30 dpi a proportion of infiltrating cardiac
cells coexpress IL-10 and IFNc and may play a beneficial role in
T. cruzi-elicited myocarditis [22]. In our study, although we were
able to detect CD8+ cells expressing IL-10 in the cardiac tissue at
45 and 120 dpi of C57BL/6 mice with the Colombian T. cruzi
strain, only a small proportion of the IL-10+ cells coexpress
IFNcdull, while in the peripheral blood the majority of IL-10+
cells coexpress IFNcbright. Thus, the putative participation of
these cells in heart injury in T. cruzi infection requires further
exploration.
Finally, to approach the differential contribution of IFNc+ and
Pfn+ cells to heart injury, we reconstituted the CD8+ cell
compartment of cd82/2 mice with CD8+ T-cells from ifnc2/2
pfn+/+ and ifnc+/+pfn2/2 donors prior to T. cruzi infection. During
the acute infection, the reconstitution of cd82/2 mice with CD8+
T-cells from ifnc2/2pfn+/+ donors (deficient in IFNc but able to
express Pfn) significantly favored the control of the parasite when
compared with non-reconstituted mice, corroborating the reports
that suggest the importance of Pfn in the protective immunity that
controls T. cruzi during the acute phase of infection [7,28].
Importantly, when naı¨ve cd82/2 mice were reconstituted with
CD8+ cells from ifnc+/+pfn2/2 naı¨ve donors (deficient in Pfn but
able to express IFNc), after infection these animals exhibited less
severe myocardial cell lesion and a more preserved electrical
conduction, with a low incidence of AVB2 and a more normal
heart rate. The reconstitution of naı¨ve cd82/2 mice with CD8+
cells from ifnc2/2pfn+/+ mice (deficient in IFNc but able to express
Pfn) prior to infection had no impact on electrical conduction,
which were similar to those found in NR cd82/2 mice, but
aggravated cardiomyocyte injury. Thus, our data support that
CD8+PfnnegIFNc+ cells act beneficially towards cardiomyocytes,
whereas CD8+Pfn+IFNcneg cells have a detrimental effect on
cardiomyocyte lesion in reconstituted T. cruzi-infected mice.
Importantly, our data showing the prevalence of CD8+Pfn+IFNcneg
cells in the cardiac tissue in chronic T. cruzi infection of C57BL/6
mice circumstantially supports a detrimental role for these cells in
heart injury.
Emerging evidence supports that cytotoxic (Pfn+, granzyme+)
and pro-inflammatory (IFNc+) CD8+ T-cell effectors may
differentially determine the outcome of infectious processes
[15,30]. In Chagas disease, the contribution of Pfn+ and IFNc+
cells to heart injury has not been determined. IFNc-producing
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CD8+ cells have been linked with protective immunity against T.
cruzi reinfection in endemic areas [8] and with a benign clinical
outcome in patients with the indeterminate and less severe form of
CCC [9]. Conversely, CD8+IFNc+ cells have been associated with
the severity of CCC [32,39]. IFNc-deficient mice are less resistant
to T. cruzi infection than their wild-type counterparts [40,41],
reinforcing the concept that IFNc participates in parasite control.
In vitro experiments showed that IFNc acts directly on T. cruzi-
infected cardiomyocytes, inducing nitric oxide production and low
trypanocidal activity, which was enhanced by addition of IL-1b,
TNF or CC-chemokines [42]. On the other hand, the presence of
granzyme A+ cytotoxic CD8+ cells in the cardiac tissue is strongly
associated with CCC severity [13]. In this context, recent findings
support the idea that although Pfn takes part in T. cruzi growth
control, this member of the lytic machinery is not crucial because
ifnc+/+pfn2/2 mice survived the acute infection and developed a
less severe chronic cardiomyopathy in an IFNc-enriched milieu
[7]. However, the direct protective effect on parasite control and
the beneficial or detrimental actions of CD8+IFNc+ and
CD8+Pfn+ cells on heart injury during T. cruzi infection have not
been explored. In this study, we present circumstantial evidence
indicating that the enrichment in H-2Kb/VNHRFTLV+ Pfn+ cells
among heart infiltrating inflammatory cells paralleled the chronic
myocardial cell injury and electrical abnormalities in chronically
T. cruzi-infected C57BL/6 mice, while H-2Kb/VNHRFTLV+
IFNc+ cells were retained in the spleen. Hence, it is conceivable to
propose that in this unbalanced compartmentalization of the T.
cruzi specific IFNc+ cells may relay the perpetuation of
Chagas’heart disease, deserving further investigation.
In summary, we demonstrate that during T. cruzi infection,
major inflammatory and cytotoxic effector activities are
performed mainly by segregated CD8+IFNc+ and CD8+Pfn+
T-cell populations. In addition, CD8+Pfn+ cells exhibit a more
frequent CCR5+LFA-1+ migratory profile that might favor the
entrance and accumulation of CD8+Pfn+ cells in the cardiac
tissue during infection. Moreover, our data support the concept
that CD8+Pfn+ T-cells are involved in cardiomyocyte injury
during T. cruzi infection, whereas CD8+IFNc+ cells play a
beneficial role in cardiomyocyte damage. Recent in vitro findings
showed that anti-TNF therapy decreases Pfn expression in
CD8+ T-cells [43]. Therefore, it is reasonable to hypothesize
that in vivo therapeutic interventions could selectively interfere
with distinct CD8+ T-cell effectors, which could hamper the
massive entry of deleterious anti-T. cruzi Pfn+ expressing cells in
the cardiac tissue but improve anti-T. cruzi protective immunity
and play a benefic role against cardiomyocyte injury, thus
opening a new avenue to be explored in Chagas’ heart disease
therapy. Lastly, we believe that distinguishing the CD8+ T-cells
effectors that contribute to the occurrence of chronic heart
lesions is a crucial goal, which will be of inestimable prognostic
value for CCC patients.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the Brazilian National Council of Animal
Experimentation (http://www.cobea.org.br/) and the Federal
Law 11.794 (October 8, 2008). The Institutional Committee for
Animal Ethics of Fiocruz (CEUA/Fiocruz, License 004/09) and
the Biosafety National Committee (CQB/CTNBio, License 105/
99) approved all the procedures used in this study.
Mice
Female C57BL/6 (H-2b), Pfn-deficient (ifnc+/+pfn2/2, B6.129-
pfn-tm1Clrk2/2), IFNc-deficient (ifnc2/2pfn+/+) and CD8-deficient
(cd82/2) mice, all in the C57BL/6 (B6) genetic background and
aged between five and seven weeks, were obtained from the
Oswaldo Cruz Foundation animal facilities (CECAL, Rio de
Janeiro, Brazil) and were maintained under specific pathogen free
conditions. In all sets of experiments three to five sex- and age-
matched noninfected controls were analyzed per time point in
parallel to five to ten infected mice, according to the experimental
protocol.
Experimental infection
C57BL/6, ifnc+/+pfn2/2 and ifnc2/2pfn+/+ mice were infected
with the Colombian T. cruzi strain by the intraperitoneal injection
of 100 blood trypomastigotes (bt). Parasitemia was estimated in
5 mL of tail vein blood. After the peak of parasitemia, the detection
of rare circulating trypomastigotes marked the onset of the chronic
phase of infection, as previously described [6].
Reagents and antibodies
For functional assays, the H-2Kb-restricted VNHRFTLV
peptide from the amastigote surface protein 2 (ASP2) [16] was
synthesized by GenScript USA Inc. (Piscataway, NJ, USA). For
flow cytometry analysis, we used the biotinylated major histocom-
patibility complex class I (MHC I) multimer H-2Kb/VNHRFTLV
produced by Proimmune (Oxford, UK), previously used to access
the specific anti-T. cruzi immune response [21], according to
manufacturer’s instructions. For use in immunohistochemistry
staining (IHS), polyclonal antibody that recognizes T. cruzi
antigens and anti-mouse CD8a (53-6.7) and anti-mouse CD4
(GK1.5) supernatants were produced in our laboratory (LBI/IOC-
Fiocruz, Brazil). The monoclonal antibodies anti-mouse Pfn
(CB5.4, Alexis Biochemicals, San Diego, CA, USA) and anti-
IFNc (R4-6A2, BD PharMingen, San Diego, CA, USA) were also
used in IHS. The biotinylated anti-rat immunoglobulin was
purchased from DAKO (Glostrup, Denmark), and the biotinylated
anti-rabbit immunoglobulin and peroxidase-streptavidin complex
were acquired from Amersham (Buckinghamshire, England).
Appropriate controls were prepared by replacing the primary
antibodies with purified rat immunoglobulin or normal rabbit
serum. For in vivo cytotoxicity assays and immunofluorescence
staining of the cells to be used in the adoptive cell transfer assays,
we used a cell trace TM CFSE cell proliferation kit (C34554) for
flow cytometry (Invitrogen, Carlsbad, CA, USA). For CD8+ T-cell
enrichment by positive selection, we used mouse CD8 Dynabeads
(LyT-2) and magnetic separation Dynal MPC (Invitrogen,
Carlsbad, CA, USA). For flow cytometry studies, FITC-, PE-
conjugated isotype controls Rat IgG, PE- and FITC-conjugated
anti-T-cell receptor ab (clone H57-597), PE- and FITC-conjugat-
ed anti-CD4 (L3T4, clone GK1.5), PE- and APC-conjugated anti-
CD8a (Ly-2, clone 53-6.7), FITC-conjugated anti-NK 1.1 (NKR-
P1B and NKR-P1C, clone PK136), PECy-7-conjugated anti-IFNc
(XMG1.2), PECy-7-conjugated anti-TNF (MP6-XT22), FITC-
conjugated anti- Pfn (11B11), PE-cy7-conjugated anti-LFA-1
(2D7) and PE-conjugated anti-CCR5 (clone C34-3448) were
purchased from BD PharMingen (San Diego, CA, USA), FITC-
conjugated anti-LFA-1 (CD11a/CD18b, clone M17/4) and PE-
conjugated anti-IL-10 (clone LRM9104) were obtained from
CALTAG (Burlingame, CA,USA), PE-conjugated anti-CD107a
(eBIO1D4B) was purchased from eBioscience (San Diego, USA).
Appropriate controls were prepared by replacing the primary
antibodies with their respective isotypes obtained from BD
PharMingen (San Diego, CA, USA) or from SouthernBiotech
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(Alabama, USA). Endotoxin-free purified anti-CD3 (clone 145 –
2C11) and anti-CD28 (clone 37.51) were purchased from South-
ernBiotech (Alabama, USA).
Immunohistochemistry (IHS)
Groups of five to seven infected and three to five noninfected
age-matched control mice were sacrificed under anesthesia at
various time points after infection. The hearts of the mice were
removed, embedded in tissue-freezing medium (Tissue-Tek, Miles
Laboratories, Elkhart, IN, USA) and stored in liquid nitrogen for
analysis by immunohistochemistry. Serial cryostat sections, 3 mm-
thick, were fixed in cold acetone and subjected to indirect
immunoperoxidase staining, as previously described [6].
For negative controls, heart tissue sections from experimentally
infected mice were subjected to similar treatments as the control
samples except primary antibodies were omitted from the
reactions. Sections of the spleen were used as positive controls
for lymphocyte staining. For each tissue section, the number of
IFNc+ inflammatory cells and Pfn+ cells were counted in 50
microscopic fields (4006 magnification). Perforin staining was
performed in accordance with the manufacturer’s instructions.
The presence of T. cruzi in cardiac tissue sections was evaluated
using a digital morphometric apparatus. The images were
analyzed using the AnaliSYS Program and the areas containing
parasite molecules were identified as amastigote nests. For each
heart sample, three separate tissue sections and 50 fields per
section were analyzed. The number of amastigote nests was
determined in 100 microscopic fields (magnification 4006) per
tissue section.
Cell preparation and intracellular cytokine staining by
flow cytometry analysis (FACS)
The mice were sacrificed by blood draining under anesthesia
and the harvested spleens were teased into single cell suspensions
as previously described [6]. For ex vivo analysis, peripheral blood
cells and splenocytes were incubated with 5 mg/mL brefeldin A
(Sigma, St. Louis, MO, USA) for 4 hours at 37uC. The cells were
collected, washed, resuspended in PBS containing 2% fetal calf
serum and labeled as previously described [6]. To prepare
mononuclear cell suspensions from cardiac tissue, 5–10 hearts
were washed to remove blood clots, minced with scissors into 1–
2 mm fragments and subjected to enzymatic digestion using a
solution containing 0.015% trypsin (T4799; Sigma, St. Louis, MO,
USA) and collagenase A (103586; Boehringer, Mannheim,
Germany), as previously described [6]. In all experiments, one-
color labeled samples were prepared for establishment of the
compensation values. The controls for specific labeling were
prepared using isotype-matched antibodies. The samples were
acquired using a BD FACScalibur (BD PharMingen, San Diego,
CA, USA) and the Beckman Coulter CyAn 7 Color flow
cytometer (Fullerton, CA, USA). The mononuclear cells were
gated and a narrow forward angle light scatter parameter was used
to exclude dead cells from the analysis. At least 100,000 cells were
acquired inside this gate. The fluorescence gates were cut in
accordance with the labeling controls, respecting the curve
inflexions. The flow cytometric analysis was carried out using
the Summit v.4.3 Build 2445 program (Dako, Glostrup, Den-
mark).
IFN-c enzyme-linked immunospot (ELISpot) assay
The ELISpot assay for the enumeration of IFNc-producing cells
was performed as previously described [17]. The assays were
performed in triplicate. The plates were coated with anti-mouse
IFNc (clone R4-6A2; BD PharMingen, San Diego, CA, USA)
antibody diluted in PBS (5 mg/mL). Further, the antigen
presenting cells were primed with total T. cruzi antigens (10 mg/
mL) for 30 minutes at 37uC. Concanavalin A (ConA, 5 mg/mL)
was used as a mitogenic stimulant. After incubation, the freshly
isolated splenocytes were seeded at a suspension of 56105 cells/
well and were incubated with the H-2Kb-restricted VNHRFTLV
peptide from ASP2 for 20 hours at 37uC and 5% CO2. A biotin-
conjugated anti-mouse IFNc antibody (clone XMG1.2; BD
PharMingen, San Diego, CA, USA) was used to detect the
captured cytokines. The spots were revealed by respective
incubation of the samples with a solution of alkaline phospha-
tase-labeled streptavidin (BD PharMingen, San Diego, CA, USA)
and a solution of nitro blue tetrazolium (NBT; Sigma, St. Louis,
MO, USA) and 5-Bromo-4-chloro-3-indolyl phosphate (BCIP;
Sigma, St. Louis, MO, USA) in Tris buffer (0.9% NaCl, 1%
MgCl2, 1.2% Tris in H2O). The mean number of spots in
triplicate wells was determined for each experimental condition
and the number of specific IFNc-secreting T-cells was calculated
by estimating the stimulated spot count / 106 cells using a CTL
OHImmunoSpot A3 Analyzer (Cleveland, OH, USA).
In vivo cytotoxicity assay
For the in vivo cytotoxicity assays, splenocytes collected from
naı¨ve C57BL/6 mice were treated with ACK buffer (Sigma, St.
Louis, MO, USA) to lyse the red blood cells. The cells were
divided into two populations and were labeled with the fluorogenic
dye carboxyfluorescein diacetate succinimidyl diester (CFSE;
Molecular Probes, Eugene, OR, USA) at a final concentration
of 5 mM (CFSEhigh) or 0.5 mM (CFSElow). CFSEhigh cells were
coated with 2.5 mM of the VNHRFTLV ASP2 peptide for
40 minutes at 37uC. CFSElow cells remained uncoated. Subse-
quently, CFSEhigh cells were washed and mixed with equal
numbers of CFSElow cells before intravenous injection (1–26107
cells per mouse) into T. cruzi-infected C57BL/6 recipients that
were sedated with diazepam (20 mg/Kg). Spleen cells from the
recipient mice were collected at 20 hours after adoptive cell
transfer, as indicated in the figure legends, fixed with 1.0%
paraformaldehyde and analyzed using the Summit v.4.3 Build
2445 program (Dako, Glostrup, Denmark). The percentage of
specific lysis was determined using the following formula:
½% CFSEhigh infected=% CFSElow infected
%CFSEhigh noninfected=% CFSElow noninfected
|100%
CD8 T-cell enrichment and in vivo leukocyte migration
assay
The spleens were removed from ifnc+/+pfn2/2 or ifnc2/2pfn+/+
donor mice at 20 days post-infection (dpi). Single-cell suspensions
of splenocytes were prepared and the red blood cells were lysed
using ACK buffer (Sigma, St. Louis, MO, USA). The splenocyte
suspensions were enriched for CD8+ cells by positive selection
(Dynabeads mouse CD8, Invitrogen Dynal AS, Oslo, Norway).
Briefly, 86107 splenic leukocytes / mL were labeled with a CD8+
enrichment antibody mixture conjugated to magnetic beads and
separated with the Dynal MPC apparatus (Invitrogen Dynal AS,
Oslo, Norway) according to manufacturer’s recommendations.
CD8-enriched cells were separated from the beads by incubating
the bead-coated cells overnight at 37uC. After incubation, the
tubes containing the cell suspensions were placed in the Dynal
MPC magnetic separator (Invitrogen Dynal AS, Oslo, Norway) for
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2 minutes and the bead-free cells were removed from the
supernatant. The CD8-enriched cells were washed three times in
sterile saline and used for adoptive transfer. The purity and
percentage of CD8+ T-cells, and the expression of IFNc and Pfn,
were determined by flow cytometry. For the adoptive cell transfer
experiments, only cell suspensions that contained a CD8-
enrichment of $98% were used. The CD8+ T-cells were labeled
with 10 mM CFSE as described above. The cell suspensions
(56106 cells per mouse) were intravenously injected into C57BL/6
and cd82/2 recipient mice at 20 dpi, that had been previously
sedated with diazepam (20 mg/Kg). As a control, C57BL/6 and
cd82/2 mice at 20 dpi received intravenous injections of 100 mL of
sterile saline. The mice were euthanized at 3, 7 and 10 days after
the adoptive cell transfer (23, 27 and 30 dpi, respectively), the
hearts were removed, and were embedded in tissue-freezing
medium (Tissue Tek, Miles Laboratories, Elkhart, IN, USA).
Serial 3 mm-thick sections were prepared, and were fixed in cold
acetone. The nuclear DNA was stained with DAPI (1 mg/mL in
PBS) in the presence of DABCO anti-fading agent (Sigma, St.
Louis, MO, USA). Using a confocal microscope (LSM 410; Carl
Zeiss, Stuttgart, Germany), the number of CFSE+ cells in 100
microscopic fields (magnification 4006) was determined and the
intensity of fluorescence determined using the program LSM
Image Browser (Carl Zeiss, Stuttgart, Germany).
CFSE-based lymphoproliferative response
The lymphoproliferative response was assessed as previously
described [44]. Briefly, the spleens were removed from noninfect-
ed or T. cruzi-infected (20 dpi) C57BL/6, ifnc+/+pfn2/2 or ifnc2/2
pfn+/+ mice, single-cell suspensions of splenocytes were prepared,
the red blood cells were lysed using ACK buffer (Sigma, St. Louis,
MO, USA) and the monononuclear cells labeled with CFSE at a
final concentration of 7 mM (CFSEhigh) or 0.5 mM (CFSElow). The
cells were incubated in RPMI medium supplemented with 10%
SBF in the presence of anti-CD3 and anti-CD28 (3 mg/mL) or
2.5 mM of the VNHRFTLV ASP2 peptide during 72 hours at
37uC and 5% CO2. The CFSE
high cells were washed and fixed
with 1.0% paraformaldehyde. The CFSElow cells were washed and
labeled with APC-conjugated anti-CD8 antibody as described
above, washed and fixed with 1.0% paraformaldehyde. All the
samples were acquired using a Beckman Coulter CyAn 7 Color
flow cytometer (Fullerton, CA, USA) and analyzed using the
Summit v.4.3 Build 2445 program (Dako, Glostrup, Denmark).
CD8+ T-cell compartment reconstitution
Splenocyte cell suspensions from noninfected ifnc+/+pfn2/2 or
ifnc2/2pfn+/+ donor mice were enriched for CD8+ T-cells as
described above and were used only when the CD8-enrichment
was $98%. CD8+ T-cells (56106 cells / recipient mouse) were
transferred intravenously into cd82/2 noninfected recipient mice.
At two weeks after the adoptive cell transfer, the recipient mice
were checked for CD8+ T-cell compartment reconstitution by
sampling 50 mL of peripheral blood, which was analyzed by flow
cytometry as described above. After the detection of CD8+ T-cells
in the peripheral blood, the recipient mice were challenged with
100 bt from the Colombian strain of T. cruzi.
Creatine-kinase detection
The activity of the creatine kinase cardiac MB isoenzyme (CK-
MB), a myocardial injury marker, was measured using a
commercial CK-MB Liquiform kit (Labtest, Brazil) in accordance
with the manufacturer’s recommendations. The incubation of sera
samples with the substrate led to a net increase in the NADPH
concentration that was directly proportional to the enzyme activity
in the samples. The assay was adapted for reading in a microplate
spectrophotometer (Microplate Reader Benchmark; Bio-Rad,
Providence, RI, USA) to allow the study of small quantities of
mouse serum in accordance with the manufacturer’s recommen-
dations. The optical density at 340 nm was recorded every
2 minutes for a duration of 15 minutes.
Electrocardiogram (ECG) registers
All mice were intraperitoneally tranquilized with diazepam
(20 mg/Kg) and the transducers were carefully placed subcuta-
neously according to chosen preferential derivation (DII). The
traces were recorded during 2 minutes using a digital system
Power Lab 2/20 that was connected to a bio-amplifier at 2 mV for
1 s (PanLab Instruments, Barcelona, Spain). Filters were stan-
dardized to between 0.1 and 100 Hz and traces were analyzed
using the Scope software for Windows V3.6.10 (PanLab
Instruments, Barcelona, Spain). We measured the heart rate
(beats per minute, bpm), the duration of the P wave and QRS, ad
PR and QT intervals in milliseconds (ms). The relationship
between the QT interval and the RR interval in the mouse was
assessed in all animals. To obtain physiologically relevant values
for the heart rate-corrected QT interval (QTc) in units of time
(rather than time to a power that is not equal to 1), the observed
RR interval (RR0) was first expressed as a unitless multiple of
100 ms, yielding a normalized RR interval, RR100 = RR0/
100 ms. Next, the value of the exponent (y) in the relationship
QT0 = QTc6RRy100 was assessed, with QT0 indicating the
observed QT (in ms) and the unit for QTc being milliseconds. The
natural logarithm was computed for each side of this relationship
[(QT0) = In (QTc)+yln (RR100)]. Thus, the slope of the linear
relationship between the log-transformed QT and RR100 defined
the exponent to which the RR interval ratio should be raised to
correct QT for heart rate [7].
Statistical analysis
The data were expressed as the arithmetic mean 6 SD. A
student’s t test was adopted to analyze the statistical significance of
the apparent differences. The Kaplan-Meier method was
employed to compare the survival rates of the groups. All
statistical tests were performed using SPSS 8.0 software.
Differences were considered statistically significant at p,0.05 (*).
Supporting Information
Figure S1 Lymphocyte populations infiltrating the car-
diac tissue of T. cruzi-infected mice. C57BL/6 mice were
infected with 100 bt of the Colombian strain of T. cruzi and
lymphocyte populations invading the cardiac tissue were evaluated
by flow cytometry at 40 dpi. (A) Representative SSCxFSC profile
of inflammatory cells isolated from cardiac tissue of T. cruzi-
infected. R1 gated cells were analyzed for TCR and CD8
expression. (B) Histogram overlay of inflammatory cells (R1 gated)
isolated from cardiac tissue of T. cruzi-infected labeled for TCR
and isotype control. Dot plot of TCR+ cells (R2 gated) stained for
CD4 and CD8. Dot plot of inflammatory cells (R1 gated) isolated
from cardiac tissue of T. cruzi-infected labeled for NK1.1 and
CD8. (C) Histogram of inflammatory cells (R1 gated) isolated from
cardiac tissue of T. cruzi-infected labeled for CD8 (R2 gated) and
TCR.
(TIF)
Figure S2 Splenomegaly and increased number of
spleen cells in T. cruzi-infected mice. C57BL/6 mice were
infected with 100 bt of the Colombian strain of T. cruzi. (A)
Relative spleen weight (mg/g) and (B) splenocyte cellularity in
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noninfected (NI; pool of three age-matched controls per analyzed
point) and T. cruzi-infected C57BL/6 mice at 15, 30, 45, 60, 90 and
120 dpi. Each circle represents an individual mouse. These data
represent three independent experiments. *, p,0.05; **, p,0.01;
and ***, p,0.001, comparing NI and T. cruzi-infected mice.
(TIF)
Figure S3 IFNc+IL-10+ cells prevailed in peripheral
blood but not in cardiac tissue of T. cruzi-infected mice.
C57BL/6 mice were infected with 100 bt of the Colombian strain
of T. cruzi and the presence of CD8+ expressing IFNc and IL-10 in
peripheral blood and cardiac tissue was evaluated by flow
cytometry (A) Representative dot plots of flow cytometry analysis
of peripheral blood CD8+ T-cells [R1 (SSCxFSC) /R2 (TCR)/R3
(CD8) gated] that were analyzed for IFNc and IL-10 expression in
T. cruzi-infected mice at 45 and 120 dpi. (B) Frequencies of
double-stained CD8+IFNc+IL-10+ and (C) CD8+IFNc+IL-10neg in
peripheral blood T-cells of heart infiltrating cells (R1/R2 gated) in
T. cruzi-infected mice at 45 and 120 dpi. (D) Representative
histograms and dot plots of flow cytometry analysis of heart
infiltrating CD8+ cells [R1 (SSCxFSC)/R2 (CD8) gated] express-
ing IFNc and IL-10 in T. cruzi-infected mice at 45 dpi.
(TIF)
Figure S4 Representative dot plots of CD8+IFNc+ ex-
pressing CCR5 and LFA-1 in T. cruzi-infected mice.
C57BL/6 mice were infected with 100 bt of the Colombian strain
of T. cruzi and the presence of CD8+IFNc+ expressing CCR5 and
LFA-1 in peripheral blood was evaluated by flow cytometry.
Representative dot plots of flow cytometry analysis of peripheral
blood cells (R1 gated) CD8+IFNc+ (R6 gated) were analyzed for
isotype controls or CCR5 and LFA-1in T. cruzi-infected mice at
45 dpi.
(TIF)
Figure S5 CD8+ cells from ifnc2/2pfn+/+ and ifnc+/+
pfn2/2 T. cruzi-infected donors were activated. C57BL/6,
ifnc2/2pfn+/+ and ifnc+/+pfn2/2 mice were infected with 100 bt of
the Colombian strain of T. cruzi and the phenotypic and
functional characterization of the CD8+ used for cell transfer to
C57BL/6 and cd82/2 infected recipients was evaluated by flow
cytometry, at 20 dpi. (A) Increased spleen cellularity in T. cruzi-
infected mice at 20 dpi. Representative histograms of flow
cytometry analysis of splenocytes [R1 (SSCxFSC) /R2 (TCR)
gated] that express TCR and CD8 in T. cruzi-infected mice at
20 dpi. (B) Representative dot plots of flow cytometry analysis of
splenocytes [R1 (SSCxFSC)/R2 (CD8) gated] that were analyzed
for expression of IFNc, Pfn, IL-10, TNF and CD107a in T. cruzi-
infected mice at 20 dpi. (C) Representative histograms of flow
cytometry analysis of splenocytes (R1 gated) of CFSEhigh-based
lymphoproliferative response after 72 hours of stimuli with anti-
CD3 and anti-CD28 in noninfected and T. cruzi-infected mice at
20 dpi. The frequencies of cycling cells (R3 and R4 gated) are
shown. (D) Representative dot plots of flow cytometry analysis of
splenocytes (R1 gated) of CFSElow-based lymphoproliferative
response after 72 hours of stimuli in T. cruzi-infected mice at
20 dpi. After stimulation, the cells were stained with APC-
conjugated anti-CD8. The cycling CFSElowCD8+ cells were
detected in gates R4 and R5. Representative flow cytometry
profiles and means of three animals per analyzed group. This
represents two independent experiments.
(TIF)
Figure S6 Noninfected recipient cd82/2 mice were
reconstituted with CD8+ cells from noninfected donors.
Representative dot plots of flow cytometry analysis of peripheral
blood cells (R1 gated) from cd82/2 mice non-reconstituted or
reconstituted with CD8+ cells from naı¨ve ifnc+/+pfn2/2 and ifnc2/2
pfn+/+ donors at 15 days after cell reconstitution stained for CD4
and CD8 molecules.
(TIF)
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